RSS Search

 News  Feeds  Images  Tags  Search Shortcuts

Feedsfarm.com > Feeds > Angiography/ Cardiac Cath News from StratCenter.com > Archive

Angiography/ Cardiac Cath News from StratCenter.com News Archive

StratWire - Complete Business of Cath Lab Newsfeed

http://www.myhealthcarenews.com/RSS/HCC0125.xml

Page: 1 of 3 Angiography/ Cardiac Cath News from StratCenter.com

  1. OrbusNeich Receives 2005 Technology Innovation Award for Its Pioneering Bio-Engineered Stent Technology
  2. Cypher Sirolimus-Eluting Coronary Stent Data Presented European Society of Cardiology Congress
  3. Medtronic Announces Key Activities at European Society of Cardiology Congress
  4. Hanford Community Med Cntr Dedicates Expanded ER
  5. NE Heart Institute’s New Home Ready at Midlands Hospital
  6. The Medicines Company to Present at Roth Capital Partners
  7. MIV Therapeutics Further Expands IP Portfolio with Milestone Addition of 2 New US Provisional Patent Applications
  8. SmallCap Sentinel: 'Innovations in Biotech ' Report Released
  9. Biosensors Starts Shipments of Axxion and Boosts European Distribution Network
  10. MIV Therapeutics Highlights Its Innovative Biomedical Technology in New Internet Presentation
  11. Innovative solutions remedy storage issues in new NE Heart Hospital
  12. Navigating the heartland
  13. Winthrop's 4th Cath Lab Opens; Unique Facility is Multi-purpose
  14. 2 New Treatment Advances Coronary Artery Disease Patients
  15. The Medicines Company to Present at Bear Stearns 18th Annual Healthcare Conference
  16. 3 Boston Scientific Drug-Eluting Stent Trials Meet ESC Treatment Guidelines for Improving Patient Outcomes
  17. CABG Medical Announces Commencement of Clinical Trials in Europe
  18. Market Pulse: Abbott carotid artery disease device gets FDA OK
  19. Abbott Receives US Approval for New Device Designed to Treat Patients at Risk of Stroke
  20. CardioTech to Present Paper on CardioPass at I-SECT
  21. Exempla accepts pay for performance program
  22. Kaleida plans $21 mln upgrade to cardiac unit
  23. Memorial Hermann heart institute opens at Memorial City campus
  24. Boston Scientific Settles With Ex-Partner
  25. Boston Scientific settles suit for $750M, but 2 more emerge
  26. Market Pulse: Boston Scientific to pay Medinol $750M in settlement
  27. Boston Scientific and Medinol Announce Settlement
  28. Guidant Meets Stent Trial Benchmark
  29. MIV Therapeutics Names Arc Rajtar to Post of CTO as Company Accelerates R&D Programs
  30. HIP Health Plan 1st MCO to Affiliate with Harvard Medical School's Mind/Body Institute
  31. Endologix Announces 1st Patient Treated in Powerlink Trial for Large Diameter Aneurysm Necks
  32. MIV Therapeutics Invests in Additional Equipment and Scientific Personnel In Reflection of R&D Program Expansion
  33. Renagel Study in New Dialysis Patients Published in Kidney International
  34. QMed and DAKOTACARE Announce CMS Approves Medicare Advantage Special Needs Plan for SD
  35. EPIX Announces European Approval of Vasovist
  36. Alternative 'Touch Therapies' May Relax Heart Patients, Says The Harvard Heart Letter
  37. Schering AG Receives EU Approval for Novel Contrast Agent Vasovist
  38. Market Pulse: EPIX Pharma gets lift from Vasovist approval in Europe
  39. Swedish Contrast Media Company Starts Clinical Phase III Studies With New Agent for MR Imaging of the Liver
  40. MedCath inks lab deal with Duke hospital
  41. Medtronic seeks US approval for drug-coated stents
  42. Medtronic Starts Endeavor FDA Submission
  43. Volcano Corp Announces Release of Version 1.4 of VH IVUS at TCT 2005
  44. El Camino Hospital Catheteriazation Lab Highlighted th Annual Transcatheter Cardiovascular Therapeutics Conference
  45. Boston Sci Says J&J Injunction in Force
  46. Boston Scientific cuts outlook amid loss
  47. Boston Scientific Reports $269M Loss in 3Q
  48. Boston Scientific Offers Hospitals Free-Stent Incentive
  49. Medtronic stent study misses goal
  50. Sorin Group: Complete 6-month Clinical and Angiographic Data Confirm Patient Safety and Efficacy Performance of Janus Drug-Eluting Stent
  51. Biopure Provides Clinical Development Update for Hemopure
  52. TAXUS clinical trial data demonstrates outstanding long-term safety & efficacy record
  53. TAXUS Clinical Trial Data Demonstrates Outstanding Long-Term Safety and Efficacy Record
  54. Medtronic stent is a me-too to J&J
  55. The CYPHER Sirolimus-Eluting Coronary Stent Outperforms the Taxus Stent in Analysis of 7 Clinical Trials
  56. Study Finds Excellent Results in Patients With Long Lesions Treated With Multiple and Overlapping CYPHER Sirolimus-Eluting Coronary Stents
  57. Spectranetics Products Featured in Multiple Live Case Sessions and Presentations at TCT Conference
  58. ABIOMED Announces Data on Its Impella Recover 2.5 Presented at TCT
  59. Boston Scientific buys endoscopy line from German firm
  60. Boston Scientific Buys Throat Stents
  61. TAXUS Stent Demonstrates Excellent Efficacy and Safety in Independent 'STENT' Registry
  62. Hospital pilot program strikes at its heart, Deborah says
  63. UAMS Among 1st in US to Install Powerful 3.0 MRI
  64. ev3 Clinical Trials and Products Featured at Recent TCT Conference
  65. Certain Personality Traits can Hurt Heart Health, Says the Harvard Mental Health Letter
  66. CABG Medical Announces Q3 2005 Results and Expands Its Clinical Trial
  67. IDX Imagecast for Cardiology Earns American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR ) Certification
  68. Guidant Completes Enrollment in Int'l Drug Eluting Stent Clinical Trial
  69. Early Initiation Of INTEGRILIN for Heart-Attack Patients in Emergency Dept Achieved Superior Coronary Artery Blood Flow
  70. Memry Corp FY 2006 Q1 Revenue $12.7M
  71. New Esomeprazole Magnesium Data in Non-cardiac Chest Pain
  72. Conor Medsystems Purchases Assets of Phytogen Life Sciences
  73. CABG Medical suspends product trial; stock falls
  74. ISMICS Publishes Consensus Statement on Beating Heart Bypass Surgery in INNOVATIONS
  75. Italian Ministry of Health Assigns Higher Price Premium to Cypher Sirolimus-Eluting Coronary Stent
  76. Memry Postpones Date of Annual Shareholders Meeting
  77. Omnicell Awarded Sole-Source Contract by Advocate Health Care
  78. FDA Clears NT-proBNP Test for New Risk Stratification Use
  79. CorNova Announces Award of ISO 13485 Certification
  80. FlowCardia Introduces 1st Products to Market and Delivers Clinical Update on the FACTOR US Pivotal Trial
  81. CorNova Announces Award of ISO 13485 Certification
  82. KAI Pharmaceuticals and Sankyo Company Enter Global Alliance to Develop and Commercialize Novel Compounds for Cardiovascular Disease
  83. NMT Medical Receives NIH Grant to Research Novel PFO Closure Technology
  84. Xceed Subsidiary PolyNovo Announces Global Partnering Deal with Medtronic
  85. FDA warns Boston Scientific; Guidant profits drop
  86. Angiotech to Buy American Medical for $785M
  87. Study Results Indicate the CYPHER Sirolimus-Eluting Coronary Stent May Reduce Re-Blockage and Chances of Side Effects in Patients with Complex Coronary Lesions
  88. Boston Scientific net up despite slower sales
  89. Spectranetics Announces Publication of LACI Trial Results in Peer-Reviewed Medical Journal
  90. Boston Scientific '05 sales jump hit by one-time charges
  91. Boston Scientific Announces French Reimbursement for TAXUS Liberte Paclitaxel-Eluting Coronary Stent System
  92. Sorin Group: Launch of 2nd Generation Drug Eluting Stent, Janus Flex With Best in Class Deliverability
  93. Sorin Group: Launch of 2nd Generation Drug Eluting Stent, Janus Flex With Best in Class Deliverability
  94. Conor CoStar Stent Gets CE Mark
  95. ev3 Receives FDA Clearance for SpideRX Embolic Protection Device for Carotid Artery Stenting
  96. Sacramento Physician Says Medical System Leaves Women at Increased Risk of Heart Attack
  97. Rita Medical Systems Launches OmniPICC PI Power Injectable Peripherally Inserted Central Catheter Product
  98. Healing Stent 9 Month Mace Rate Similar to Drug Eluting Stents
  99. Boston Scientific to Release Broad Range of Clinical Study Results on Taxus Coronary Stent System at ACC 2006
  100. CardioTech Plans Abbreviated Trial for CardioPass Based on Notified Body Response